Journal Article (227)
41.
Journal Article
12 (Suppl. 3), pp. S139 - S140 (2002)
The place of peptide systems in major depression and anxiety. European Neuropsychopharmacology 42.
Journal Article
114 (7), p. O107 - O107 (2002)
Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Medical Genetics 43.
Journal Article
114 (7), p. P28 - P28 (2002)
Somatic complaints and somatosensory ERPs as vulnerability markers for affective disorders. American Journal of Medical Genetics 44.
Journal Article
4 (2), pp. 87 - 91 (2002)
Congenital myasthenia in Brahman calves caused by homozygosity for a CHRNE truncating mutation. Neurogenetics 45.
Journal Article
114 (7), p. P36 - P36 (2002)
The combined dexamethasone-suppression/corticotropin-releasing- hormone(CRH) stimulation test, a possible endophenotype for major depression? American Journal of Medical Genetics 46.
Journal Article
12 (Suppl. 3), p. S148 - S148 (2002)
Patterns of familial aggregation of anxiety and depressive disorders in the community. European Neuropsychopharmacology 47.
Journal Article
68 (2), pp. 195 - 207 (2002)
Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug and Alcohol Dependence 48.
Journal Article
17 (6), pp. 321 - 331 (2002)
The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study. European Psychiatry 49.
Journal Article
71 (4 Suppl. Suppl. S), p. 324 - 324 (2002)
Growth hormone expression on mRNA level is significantly reduced in the brain of Ndp-knockout-mice. American Journal of Human Genetics 50.
Journal Article
114 (7), p. P359 - P359 (2002)
Essential role of limbic corticotropin-releasing hormone receptor I in neuroendocrine adaptation to stress and anxiety- related behavior. American Journal of Medical Genetics 51.
Journal Article
12 (Suppl. 3), p. S201 - S201 (2002)
Increased activity of the renin-angiotensin-aldosterone system in patients with depression - A sleep-endocrine study. European Neuropsychopharmacology 52.
Journal Article
12 (Suppl. 3), p. S124 - S124 (2002)
Chronic effects of perinatal stress: Dependency on gender and the genetic predisposition. European Neuropsychopharmacology 53.
Journal Article
12 (Suppl. 3), p. S341 - S341 (2002)
Valproate in the treatment of posttraumatic stress disorder: An open-label study. European Neuropsychopharmacology 54.
Journal Article
27 (4), pp. 638 - 645 (2002)
Repetitive transcranial magnetic stimulation (rTMS) in major depression: Relation between efficacy and stimulation intensity. Neuropsychopharmacology 55.
Journal Article
12 (10), pp. 1537 - 1546 (2002)
Cushing's syndrome: drug targets and therapeutic options. Expert Opinion on Therapeutic Patents 56.
Journal Article
16 (5), pp. 525 - 532 (2002)
Low levels of circulating inflammatory cytokines - Do they affect human brain functions? Brain Behavior and Immunity 57.
Journal Article
131 (1-2), pp. 126 - 134 (2002)
Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice. Journal of Neuroimmunology 58.
Journal Article
143 (10), pp. 3759 - 3765 (2002)
Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology 59.
Journal Article
22 (19), pp. 8676 - 8683 (2002)
The neuronal nitric oxide synthase gene is critically involved in neurobehavioral effects of alcohol. Journal of Neuroscience 60.
Journal Article
17 (5), pp. 928 - 933 (2002)
Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of Dopaminergic treatment. Movement Disorders